Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials

BACKGROUND: BUP-XR (a.k.a. RBP-6000 or SUBLOCADE™) is an extended-release subcutaneous buprenorphine formulation for the treatment of opioid use disorder. BUP-XR was designed to provide sustained buprenorphine exposure throughout the monthly dosing interval, at concentrations sufficient to control a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Aksana K., Ngaimisi, Eliford, Gopalakrishnan, Mathangi, Young, Malcolm A., Laffont, Celine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016750/
https://www.ncbi.nlm.nih.gov/pubmed/33135125
http://dx.doi.org/10.1007/s40262-020-00957-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016750/
https://www.ncbi.nlm.nih.gov/pubmed/33135125
http://dx.doi.org/10.1007/s40262-020-00957-0

Ejemplares similares